84 results
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
Revenue Agency, Internal Revenue Service and the U.S. Treasury Department. Changes to tax laws, or changes in interpretations of existing laws (which … , an agency within the U.S. Department of Health and Human Services, or HHS. CMS decides whether and to what extent a new product will be covered
8-K
EX-1.1
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Entry into a Material Definitive Agreement
4:15pm
. Government (including, without limitation, Office of Foreign Assets Control of the U.S. Treasury Department), the United Nations Security Council … . Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory
424B5
w3e 3amkdw
29 Nov 23
Prospectus supplement for primary offering
5:05pm
424B5
4uozs 27np
23 Jun 22
Prospectus supplement for primary offering
4:09pm
8-K
EX-1.1
80mbdgp
23 Jun 22
Other Events
4:04pm
424B5
nz5ai2f6xbnlz5194
22 Jun 22
Prospectus supplement for primary offering
4:05pm
8-K
EX-10.1
y4pworxx3k3ch5z 7o05
12 Jan 22
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory Milestone
8:04am
8-K
EX-10.1
67c9q
1 Dec 21
Entry into a Material Definitive Agreement
4:02pm